Beech Hill Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Beech Hill Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	+1,768	New	+$1.2M	0.49%	66

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Beech Hill Advisors's REGN Position: Q2 2026 in Review

Beech Hill Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1,768 shares worth $1.1M. The stake represents 0.49% of the portfolio and ranks #66 among its holdings.

518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Beech Hill Advisors held 1,768 shares of Regeneron Pharmaceuticals worth $1.1M as of Q2 2026.
Regeneron Pharmaceuticals was a new Beech Hill Advisors position in Q2 2026.
Regeneron Pharmaceuticals made up 0.49% of Beech Hill Advisors's portfolio in Q2 2026, its #66 holding.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Beech Hill Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.